STAAR Surgical Co Restructuring Costs and Asset Impairment Charges
STAAR Surgical Co (STAA) reported Restructuring Costs and Asset Impairment Charges of $0 for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2026-08-12
- STAAR Surgical Co restructuring costs and asset impairment charges for the quarter ending 2026-07-03 was $0.00, a 100.00% decline year-over-year.
- STAAR Surgical Co restructuring costs and asset impairment charges for the quarter ending 2026-04-03 was $2.68M, a 88.17% decline year-over-year.
- STAAR Surgical Co restructuring costs and asset impairment charges for the quarter ending 2026-01-02 was $694.00K.
- STAAR Surgical Co restructuring costs and asset impairment charges for the quarter ending 2025-09-26 was $26.00K.
- STAAR Surgical Co restructuring costs and asset impairment charges for fiscal 2026 was $28.63M.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2026-07-03 | $0.00 10-Q · filed 2026-08-12 | $2.68M 10-Q · filed 2026-08-12 | $3.38M derived: sum of 3 quarters · filed 2026-08-12 | $3.40M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $2.68M 10-Q · filed 2026-05-13 | $3.38M derived: sum of 2 quarters · filed 2026-05-13 | $3.40M derived: sum of 3 quarters · filed 2026-05-13 | $8.65M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $720.00K derived: sum of 2 quarters · filed 2026-03-03 | $5.97M derived: sum of 3 quarters · filed 2026-08-12 | $28.63M 10-K · filed 2026-03-03 |
| 2025-09-26 | $26.00K 10-Q · filed 2025-11-05 | $5.27M derived: sum of 2 quarters · filed 2026-08-12 | $27.94M 10-Q · filed 2025-11-05 | |
| 2025-06-27 | $5.25M 10-Q · filed 2026-08-12 | $27.91M 10-Q · filed 2026-08-12 | ||
| 2025-03-28 | $22.66M 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |